|
2025
|
Invention
|
Pharmaceutically acceptable salts and compositions thereof.
Pharmaceutically acceptable salts of... |
|
|
Invention
|
5-methoxy-n,n-dimethyltryptamine (5-meo-dmt) formulations.
The present invention provides a dry ... |
|
|
Invention
|
5-methoxy-n,n-dimethyltryptamine (5-meo-dmt) powder formulations. The present invention provides ... |
|
2024
|
Invention
|
N-acetylserotonin (nas) analogues. 11010 are defined herein. |
|
|
Invention
|
Pharmaceutical compositions comprising 5-methoxy-n,n-dimethyltryptamine (5-meo-dmt). Pharmaceutic... |
|
|
Invention
|
Pharmaceutical compositions comprising 5-methoxy-n,n-dimethyltryptamine (5-meo-dmt). This inventi... |
|
|
Invention
|
5-methoxy-n,n-dimethyltryptamine (5-meo-dmt) pharmaceutical compositions. This invention relates ... |
|
|
Invention
|
5-methoxy-n,n-dimethyltryptamine (5-meo-dmt) formulations. The present invention provides a dry p... |
|
2023
|
Invention
|
Formulations of 5-meo-dmt. A pharmaceutically acceptable composition may include 5-methoxy-N,N-di... |
|
|
G/S
|
Pharmaceuticals for the treatment of psychiatric and neurological conditions; medical preparation... |
|
|
Invention
|
Ergoline analogues. This invention relates to pharmaceutically acceptable ergoline analogues and ... |
|
|
Invention
|
Pharmaceutically acceptable 5-methoxy-n,n-dimethyltryptamine salts and compositions thereof. This... |
|
|
Invention
|
Pharmaceutically acceptable salts and compositions thereof. Pharmaceutically acceptable salts of ... |
|
|
Invention
|
Ergoline and tryptamine-based compounds, and uses of the same. This invention relates to pharmace... |
|
|
Invention
|
Pharmaceutical composition comprising 5-methoxy-n,n-dimethyltryptamine.
An intranasal compositio... |
|
|
Invention
|
Composition comprising a benzoate salt of 5-methoxy-n,n-dimethyltryptamine.
A composition compri... |
|
2022
|
Invention
|
Benzoate salt of 5-methoxy-n,n-dimethyltryptamine. A method of synthesizing the benzoate salt of ... |
|
|
Invention
|
Pharmaceutical composition. A method of producing polymorph A' of psilocybin, the method comprisi... |
|
|
Invention
|
Pharmaceutical composition comprising 5-methoxy-n,n-dimethyltryptamine. An intranasal composition... |
|
|
Invention
|
Composition comprising a benzoate salt of 5-methoxy-n,n-dimethyltryptamine. A composition compris... |
|
|
G/S
|
Pharmaceuticals; pharmaceutical and medical preparations;
psychedelics; psychedelic compounds; p... |
|
|
Invention
|
Tryptamine analogues.
This invention relates to pharmaceutically acceptable tryptamine analogues... |
|
|
Invention
|
Tryptamine analogues. This invention relates to pharmaceutically acceptable tryptamine analogues ... |
|
2021
|
Invention
|
Pharmaceutical composition comprising psilocybin or its polymorphs. A composition for use in a me... |
